Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids
1 / 4Opioid Crisis Purdue BankruptcyFILE - In this April 2, 2018, file photo, a pharmacist in San Francisco poses for photos holding a bottle of OxyContin. In court papers filed in New York on Sunday, Sept. 15, 2019, Purdue Pharma, the drug's manufacturer, flied for Chapter 11 bankruptcy protection.
In a statement, the families of late company owners Mortimer and Raymond Sackler said they have"deep compassion for the victims of the opioid crisis" and believe the settlement framework"is an historic step toward providing critical resources that address a tragic public health situation." "We are hopeful that in time, those parties who are not yet supportive will ultimately shift their focus to the critical resources that the settlement provides to people and problems that need them," they said.
The Sacklers have given money to cultural institutions around the world, including the Smithsonian Institution, New York City's Metropolitan Museum of Art and London's Tate Modern. Purdue's drugs are just a slice of the opioids prescribed, but critics assign a lot of the blame to the company because it developed both the drug and an aggressive marketing strategy.
The Associated Press and the Center for Public Integrity found the industry and groups it funded were also politically active, spending more than $880 million nationally on lobbying and campaigns from 2006 through 2015. That spending helped the industry fight off restrictions on prescribing the powerful painkillers.
One lawyer who is suing Purdue on behalf of clients including the city of Albuquerque, New Mexico, and the state of Utah, which has signed on to the tentative settlement, said it's long been a consideration that Purdue could not afford to pay the massive amounts being sought in the lawsuits.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
OxyContin Maker Purdue Pharma Files for Bankruptcy ProtectionPurdue Pharma filed for bankruptcy protection with a partial deal aimed at resolving thousands of lawsuits filed by states and local municipalities accusing it of fueling the opioid crisis.
Consulte Mais informação »
Purdue Pharma, maker of painkiller OxyContin, files for bankruptcyThe bankruptcy means that Purdue will likely be removed from the first federal opioid trial, scheduled to start in Cleveland on Oct. 21.
Consulte Mais informação »
OxyContin maker Purdue Pharma files for bankruptcy protectionDrone strikes attacked an oil processing facility at Abqaiq and the nearby Khurais oil field on Saturday.
Consulte Mais informação »
OxyContin maker Purdue Pharma files for bankruptcy protectionThe company that made billions selling the prescription painkiller OxyContin filed for bankruptcy in days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids.
Consulte Mais informação »
Purdue Pharma, the drugmaker behind OxyContin, files for bankruptcy as part of a major settlementThe company declared bankruptcy days after reaching a tentative settlement with many state and local governments suing it in connection to the US opioid epidemic.
Consulte Mais informação »
OxyContin Maker Purdue Pharma Files For Bankruptcy Over Opioid SettlementThe Chapter 11 filing, approved on Sunday, comes after a tentative deal struck with dozens of states to settle thousands of lawsuits over Purdue's alleged role in the opioid crisis.
Consulte Mais informação »